Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated May 8, 2023 (3 years ago)

Methylprednisolone Acetate Injectable Suspension

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number 70121-1574-1.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue Injection Only, Not for Intravenous Use, 1 mL Single Dose Vial, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Parenteral Unit, Ahmedabad 382213, India, Amneal Pharamceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1574-01.

Affected NDC 70121-1574-01

Compare with the code on your package — it is the most precise check available.

Drug: Methylprednisolone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Methylprednisolone acetate
NDC 70121-1574
80 mg/mL Injection, Suspension
Intra-Articular|intralesional|intramuscular|soft Tissue
Amneal Pharmaceuticals LLC Rx
Recalling firm
Amneal Pharmaceuticals of New York, LLC
NDC code
70121-1574-01
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0756-2023 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Methylprednisolone recalls

See all
Class II · Moderate risk

methylprednisolone tablets

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.

Ongoing Labeling / mix-up Greenstone Llc NDC 59762-4440-2 D-0299-2026
Class II · Moderate risk

Depo-Medrol

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3475-01 D-1097-2022

Other recalls by Amneal Pharmaceuticals of New York, LLC

All 2023 recalls
Class II · Moderate risk

Exenatide Injection

Defective Delivery System: Possibility of no medication in the prefilled pen.

Ongoing Packaging defect Amneal Pharmaceuticals of New York, LLC NDC 70121-1685-1 D-0868-2026